https://apxora.com/news News, press, editorial and events from Apxora — SequenceFlow™. en https://apxora.com/news/biotech-week-basel-2026 biotech-week-basel-2026 event Tue, 22 Sep 2026 00:00:00 GMT Talks and demos on running forecasting and launch sequencing as a continuous flow — on home ground in the European pharma cluster. https://apxora.com/news/bio-international-2026 bio-international-2026 event Mon, 08 Jun 2026 00:00:00 GMT Live SequenceFlow™ walkthroughs by appointment. Founders on-site across the week for operator, partner and investor meetings. https://apxora.com/news/south-summit-madrid-2026 south-summit-madrid-2026 event Wed, 03 Jun 2026 00:00:00 GMT Three days at one of Europe's leading innovation and investment platforms. Founder meetings, healthtech panels and 1:1s with global investors and corporates. https://apxora.com/news/ny-tech-week-2026 ny-tech-week-2026 event Tue, 02 Jun 2026 00:00:00 GMT Apxora joins a curated cohort of Swiss founders showcasing deep-tech and life sciences AI to NYC investors and operators — part of the Startup Camps programme powered by Innosuisse. https://apxora.com/news/decision-layer-for-life-sciences decision-layer-for-life-sciences editorial Wed, 20 May 2026 00:00:00 GMT Drug development runs on a chain of high-stakes decisions, yet the tooling stops at reporting. SequenceFlow™ closes the loop from data to decision. https://apxora.com/news/nvidia-inception-membership nvidia-inception-membership announcement Wed, 06 May 2026 00:00:00 GMT Access to NVIDIA's GPU compute and technical experts to accelerate the simulation engines at the core of SequenceFlow™. https://apxora.com/news/probabilistic-forecasting-explained probabilistic-forecasting-explained editorial Tue, 28 Apr 2026 00:00:00 GMT A single NPV number hides the one thing decision-makers need most — the shape of the risk. Here is how we model it instead. https://apxora.com/news/2026-patent-cliff-inflection 2026-patent-cliff-inflection editorial Sun, 15 Mar 2026 00:00:00 GMT As a wave of blockbusters lose exclusivity, the winners will be the teams that can re-sequence their portfolios fastest — continuously, not once a year. https://www.startupticker.ch/ swiss-deeptech-to-watch press Thu, 19 Feb 2026 00:00:00 GMT Coverage of the Basel-based decision-engine company building probabilistic forecasting for life sciences. https://apxora.com/news/iso-27001-certified iso-27001-certified announcement Thu, 22 Jan 2026 00:00:00 GMT Independent certification of Apxora's information security management system. SOC 2 is in progress. https://apxora.com/news/microsoft-ai-accelerator-selection microsoft-ai-accelerator-selection press Fri, 22 Nov 2024 00:00:00 GMT Apxora joins Microsoft for Startups — Founders Hub and the Swiss Microsoft AI Accelerator, gaining production-grade Azure compute and access to Microsoft's life sciences ecosystem.